DENISE CULPEPPER: Open Payments
NPI 1669782710 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 24 payments from 12 companies in 2025. Trend: 2023 $945 · 2024 $995 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $127 |
| Abbott Laboratories | 3 | $100 |
| Exact Sciences Corporation | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $43 |
| Radius Health, Inc. | 1 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| GENZYME CORPORATION | 1 | $24 |
Products named: REXULTI, Cologuard Collection Kit, PROCLAIM, TRELEGY ELLIPTA, JARDIANCE, Wegovy, Tymlos, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
